FDA Approves Arcutis’ Zoryve® (Roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age
FDA批准Arcutis的Zoryve® (Roflumilast)霜0.15%用於治療兒童至6歲及成人的特應性皮炎
FDA Approves Arcutis’ Zoryve® (Roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age
FDA批准Arcutis的Zoryve® (Roflumilast)霜0.15%用於治療兒童至6歲及成人的特應性皮炎
使用瀏覽器的分享功能,分享給你的好友吧